Post 2020, biopharma marketing is never going to be the same. Digital marketing is no longer an optional component of a go-to-market strategy for biopharma companies. In fact, digital engagement is penetrating and transforming the way pharma delivers care across many different channels.
To stay ahead of the curve, organizations need to rapidly adopt and integrate new tools and practices to educate key customers, improve reach, enhance speed, raise sales force effectiveness, measure and increase customer satisfaction, and offset declining HCP access.
Best Practices, LLC undertook this research to identify how leading biopharma companies are adopting an integrated omnichannel marketing strategy by maximizing their key digital assets. The report establishes industry benchmarks around digital marketing service structure, digital marketing staffing and investment, digital operations, innovative tools, digitizing new product planning and launch, performance measurement, mobile engagement and digital health, and key channels and activities.